日韩成人一区二区三区在线观看,亚洲爆乳成av人在线视菜奈实,一级特黄aaa大片在线观看成人一级片在线观看,欧美一级a视频在线观看,久久综合狠狠色综合伊人,国产亂倫近親相姦视频,日韩免费无码视频一区二区三区,97久久精品亚洲中文字幕无码,久爱无码精品免费视频,超碰97人人模人人爽人人

Vaccine
Home > Application > Vaccine > Virus-like particle (VLP) vaccine

Virus-like particle (VLP) vaccine


Most currently available vaccines are mainly based on inactivated or attenuated live vaccines. Although these traditional vaccines have been used effectively against various infectious diseases, some of them have several limitations, including low likelihood of inducing a stronger immune response and their poor efficacy. Recent outbreaks of infectious diseases demonstrate the need to develop robust vaccines to overcome these limitations. The main challenge is to develop new technical approaches and boost immunity without compromising safety, efficacy and tolerability. Recent advances in vaccines based on DNA, mRNA, and recombinant viral vectors provide effective vaccine development methods for difficult-to-target pathogens and control infectious disease outbreaks.

 

Virus-like particle (VLP) technology provides an alternative platform for the development of effective vaccines against serious infectious diseases, and it is being developed in parallel with vaccines based on mRNA and viral vectors. VLPs are also much more immunogenic than other subunit vaccines because they present repetitive epitopes on their surface, making them more reliably detectable by the immune system. On the other hand, subunit vaccines may be less immunogenic due to misfolding of the target antigen or insufficient presentation to the immune system, and moreover, they require adjuvants and repeated vaccinations to elicit an adequate immune response. The term virus-like particle was first described by Fraenkel-Conrat and Williams (1955) by recombining tobacco mosaic virus (TMV) particles from purified RNA and protein components. The potential of these nanostructures to induce potent immune responses was then further investigated. The VLP platform can overcome various problems typically associated with traditional vaccines; specifically, infectivity, reversion to virulent forms, mutation risk associated with live attenuated vaccines, and reduced immunogenicity, toxicity instability, low yield and long formulation time associated with inactivated vaccines.

 

These bio-inspired nanostructures feature repetitive and high-density antigens from different viruses, helping to trigger a strong immune response. Furthermore, these highly immunogenic molecules possess the self-assembling properties of viral proteins. They are biocompatible and have the potential for structural flexibility during synthesis. They can be chemically or genetically modified and exhibit increased stability, uniformity, and functionality, and are considered effective tools in various biomedical applications. Depending on the presence or absence of a lipid membrane, VLPs can be classified as either enveloped or nonenveloped.

 

However, some of the key challenges associated with VLPs are low stability, difficult downstream processes, high production costs, and sensitivity to environmental conditions. Many different VLPs have been synthesized in various expression systems, such as bacteria, yeast, mammalian cells, insect cells, and plants. VLP-based vaccines have the potential to be used to treat various infectious diseases, including HIV, influenza, hepatitis B, hepatitis E, malaria, Ebola virus, SARS-CoV-2, Zika virus, dengue fever, and foot-and-mouth disease, among others. Several VLP-based vaccines have been licensed and marketed, including Engerix-B? and Recombivax HB? for HBV, Gardasil? and Cervarix? for HPV, Hecolin? for HEV, and Mosquirix? for malaria.


Related Products
Contact Us
  • Tel.: +86 021 6434 0155
  • E-Mail: marketing@duoningbio.com
  • Address: Building 30, No. 1525 Minqiang Road, Songjiang District, Shanghai
Message

Copyright ? Shanghai Duoning Biotechnology Co., Ltd. All Rights Reserved Sitemap | Technical Support: Reanod

WeChat
WeChat

Message-

Duoning Biotechnology

+86 021 6434 0155

天堂а√中文在线官网| 一区二区免费国产在线观看| 忘忧草在线影院www日本| jlzz日本人年轻护士出水视频| 夜夜夜91精品欧美一区| 风流老熟女一区二区三区| 国产一区私人高清影院| 欢迎访问欧美成人精品第一区二区三区| 一级a性色生活片久久无国产| 18在线观看国内精品视频| 日本护士高潮叫床声| 137啪啪肉体摄影男女骚视频| 亚洲天堂中文字幕在线观看电影| 精品国产自在在线午夜精品| 巨胸的教师在线完整版中文| 成人H动漫精品一区二区无码| 久久久久免费精品国产| 国产精品成人一区无码| 国产AV激情久久无码天堂| 亚洲高清无码一二三区A片| 国产成人精品一区二三区熟女| 露脸美乳小情人456| 婷婷午夜天午夜福利综合| 精品人妻一区二区三区浪潮在线| 国产乱子伦精品无码码专区| 亚洲国产成人精品一区二区三区自拍| 色色视频网亚色中文91在线| 国产成人精品久久亚洲高清不卡| 18禁止观看网站A级毛片自慰| 久久婷婷色综合网站| 一级做a爰片久久毛片A片秋霞天| 国产乱妇乱子在线播视频播放网站| 中文字幕日韩精品中文区| 久久青青草原精品老司机| 久久国产精品偷导航| 51国偷自产一区二区三区| 久久精品国 1080P 国产一区二区三区不卡av| 亚洲精品一品区二品区三品区| 亚洲欧美日韩国产成人精品影院| 亚洲国产中文成人无码影片在线| 真人作爱90分钟免费看视|